Two-dose SARS-CoV-2 vaccine effectiveness with mixed schedules and extended dosing intervals: test-negative design studies from British Columbia and Quebec, Canada

Danuta M Skowronski; Solmaz Setayeshgar; Yossi Febriani; Manale Ouakki; Macy Zou; Denis Talbot; Natalie Prystajecky; John R Tyson; Rodica Gilca; Nicholas Brousseau; Geneviève Deceuninck; Eleni Galanis; Chris D Fjell; Hind Sbihi; Elise Fortin; Sapha Barkati; Chantal Sauvageau; Monika Naus; David M Patrick; Bonnie Henry; Linda M N Hoang; Philippe De Wals; Christophe Garenc; Alex Carignan; Mélanie Drolet; Manish Sadarangani; Marc Brisson; Mel Krajden; Gaston De Serres

bioRxiv (2021) - Comments
doi: 10.1101/2021.10.26.21265397

Danuta M Skowronski, Solmaz Setayeshgar, Yossi Febriani, Manale Ouakki, Macy Zou, Denis Talbot, Natalie Prystajecky, John R Tyson, Rodica Gilca, Nicholas Brousseau, Geneviève Deceuninck, Eleni Galanis, Chris D Fjell, Hind Sbihi, Elise Fortin, Sapha Barkati, Chantal Sauvageau, Monika Naus, David M Patrick, Bonnie Henry